西玛试剂
电话/微信:18622987668
|
Symeres 品牌介绍We are the leading transatlantic small molecule contract research and manufacturing organization that has been a trusted global partner for biotech and pharma companies for over 30 years.
Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug-discovery and development challenges. With around 600 highly educated scientists in six locations in Europe and the US, we offer best-in-class solutions for drug discovery and drug development, from small to medium-sized molecule hits. We are large enough to matter, and small enough to care. Our services span across early stage hit finding all the way to the delivery of your early clinical drug substance API. Making Molecules Matter. Together. Symeres是一家总部位于荷兰奈梅亨的全球药物发现公司,收购了总部位于新泽西州克兰伯里的综合药物开发服务提供商 Exemplify BioPharma 。交易金额未披露,通过此次收购,Symeres 将进一步巩固其在美国的战略地位。Exemplify BioPharma 由首席执行官 Yadan Chen 领导,是一家为制药和生物技术合作伙伴提供综合小分子化学制造和控制服务的供应商。该公司提供过程化学、分析化学和配方开发方面的咨询服务,以成功地将项目从后期优化过渡到候选人选择到首次人体试验。 Exemplify 拥有 20 名员工,其中大多数是博士级科学家。 Symeres 由首席执行官 Eelco Ebbers 领导,是一家满足药物发现和开发需求的中型跨大西洋合同研究组织,在荷兰、捷克共和国、芬兰和美国的 7 个地点拥有约 600 名员工。该公司为小分子及其他领域的药物发现和药物开发提供解决方案。他们的服务范围从临床前发现一直到早期临床阶段药物 API 的交付。 Exemplify BioPharma 是 Symeres 今年在美国的第二次收购,此前该公司收购了位于波士顿地区的有机化学服务提供商 Organix Inc.,该公司专门从事针对 mRNA 治疗和疫苗市场的脂质业务。 |